# SOTERA HEALTH COMPANY (SHC) · Edgar & Edgarette company card

> Sotera Health Company (SHC) grew revenue 5.7% in FY2025 to $1.2 billion, equity 18.6% of assets. Every figure is from the company’s own annual report filed with the SEC.

SEC CIK 1822479 · fiscal year ended 2025-12-31 · 5 audited years read · [page](https://www.pops4.com/boards/company/SHC) · [JSON](https://www.pops4.com/boards/company/SHC.json)

## Figures, as filed in the 10-K

| Measure | Value |
|---|---|
| Revenue | $1.2B |
| Revenue growth, 1 year | 5.7% |
| Revenue growth per year | 5.7% |
| Operating margin | — |
| Net margin | 6.7% |
| Operating cash flow | $287M |
| Capital spending | $138M |
| Free cash flow | $149M |
| Cash | $345M |
| Long-term debt | $2.1B |
| Total assets | $3.3B |
| Total equity | $606M |
| Equity ÷ assets | 18.6% |
| Return on equity | 12.9% |
| Dividend per share | — |
| Dividend years rising | — |

## Readings, computed from those figures

- Piotroski F: 6 of 9 (solid)
- Health Harbor boat: New ship · no warning signs
- Cash Compass: In between · no clear cash pattern yet

## Edgarette's reading

Exposure: revenue $1.2B (FY2025), total debt $2.1B. Experience: revenue up 5.7% on the year, up 5.7% a year over 4 years. Soundness: equity 18.6% of assets, return on equity 12.9%. Credibility: four or more audited years, reasonable weight. Range: 80% of past cases like this landed between $1.1B and $1.3B next year (method v4.1: its own 4-year record of growth weighed at 50% against $1B–10B filers; across 2019–2025, 69.0% landed inside, 83.4% on the one year the method never saw). In a shock year the stress range is $1.0B to $1.4B. A statistical range, not company guidance. Against peers (54 filers, $50M+ revenue, its industry group): growth 5.7% against 13.0%.

Range logged 2026-11-01, receipt 878b5c6159bd56da, status open. A statistical range, not company guidance.

## Health Watch, last 12 months

- Item 5.02 Director or officer change: 5, latest 2026-08-14 ([filing](https://www.sec.gov/Archives/edgar/data/1822479/000182247926000050/0001822479-26-000050-index.htm))

## Recent filings

- 10-Q · filed 2026-11-03 · [filing](https://www.sec.gov/Archives/edgar/data/1822479/000182247926000058/0001822479-26-000058-index.htm)
- 8-K · filed 2026-11-03 · 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1822479/000182247926000055/0001822479-26-000055-index.htm)
- 8-K · filed 2026-08-14 · 5.02 Departure or Election of Directors; Appointment of Officers · [filing](https://www.sec.gov/Archives/edgar/data/1822479/000182247926000050/0001822479-26-000050-index.htm)
- 10-Q · filed 2026-08-06 · [filing](https://www.sec.gov/Archives/edgar/data/1822479/000182247926000047/0001822479-26-000047-index.htm)
- 8-K · filed 2026-08-06 · 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1822479/000182247926000044/0001822479-26-000044-index.htm)
- 8-K · filed 2026-05-22 · 5.07 Submission of Matters to a Vote of Security Holders · [filing](https://www.sec.gov/Archives/edgar/data/1822479/000182247926000034/0001822479-26-000034-index.htm)

## Sources

- facts: https://data.sec.gov/api/xbrl/companyfacts/CIK0001822479.json
- filings: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1822479

## Cite

POPS4, Edgar & Edgarette: SOTERA HEALTH COMPANY (SHC) company card, from the company's own SEC filings, accessed 2026-11-21, https://www.pops4.com/boards/company/SHC. CC BY 4.0. For a figure, add the filing URL under filings or sources.

DOI https://doi.org/10.5281/zenodo.23672509 · catalog https://www.pops4.com/boards/catalog.json · Figures as filed with the SEC. Card text CC BY 4.0, POPS4.

Reporting, not investment advice. No price targets and no trading recommendations.

Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.

